Sail For Epilepsy is excited to announce that Neurelis, Inc. has become an Admiralty level sponsor of Sail For Epilepsy. In addition to the development and commercialization of product candidates for epilepsy and the broader central nervous system (CNS) market, Neurelis is committed to working with the epilepsy community to increase the quality of their lives. “When I first spoke with CEO Craig Chambliss, as well as other members of his leadership team, I was struck by Neurelis’ passion for helping the patient. It was not just about marketing a drug, but how they can make people’s lives better,” said Phil Haydon, President of Sail For Epilepsy.
“We are very pleased to partner with Sail For Epilepsy in its efforts to raise awareness about epilepsy,” said Craig Chambliss, President and Chief Executive Officer of Neurelis, Inc. “Given our shared commitment to helping patients and those who care for them, we were excited to support Sail For Epilepsy’s mission to educate thousands of people around the world about epilepsy.”
Neurelis’ multi-year support of Sail For Epilepsy at the highest level of sponsorship is evidence of their commitment to the epilepsy community. Through their support, Sail For Epilepsy will be able to move forward on a number of goals that will enable the project to set sail as planned. Sail For Epilepsy welcomes all of Neurelis as virtual shipmates for this voyage across the world’s oceans – and on the shared journey to inspire people with epilepsy, their families, and their caregivers to take One More Step to live their lives to the fullest extent possible.
Neurelis, based in San Diego, CA, is an innovation-driven neuroscience company providing a highly differentiated approach to target unmet medical needs in managing epilepsy. On January 10, 2020, the U.S. Food and Drug Administration (FDA) approved Neurelis’ first commercial product. Visit www.Neurelis.com to learn more.
Neurelis emphasizes highly differentiated therapies that empower patients, care partners, and healthcare providers. The benefits of their unique approach allows them to form strategic partnerships to address significant unmet needs in medical and therapeutic areas.
For more information on Neurelis, please visit www.Neurelis.com.